ORPHELIA Pharma

Member of Lyonbiopole

ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon specialized in the development and commercialization of medecines for the treatment of rare and pediatric diseases.

ORPHELIA Pharma’s mission is to provide patients with essential medicines and improve their quality of life in the fields of neurology and oncology with formulations adapted to the pediatric population.

Strategic application domain: Human Medicine

Application market: Neurology & Mental Health Disorders, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Small Molecules, Others

Created on april 2^nd, 2007 - 10 employees

Address

85 Boulevard Saint Michel 75005 Paris

Visit Website

Contacts

Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.

Actualités récentes

ORPHELIA Pharma Selects Tanner Pharma Group

To Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries

18 avril 2023

ORPHELIA Pharma annonce la fin du recrutement de son essai clinique TEMOkids

TEMOkids évalue la suspension buvable prête à l’emploi de témozolomide appelée KIMOZO® ou Ped-TMZ, chez l’enfant atteint d’une tumeur solide à partir de 1 an.

3 mars 2023